Protagonist's pipeline leverages its proprietary Vectrix platform to target obesity, hematology, and inflammation. Find out ...

Rail Vision Ltd. (Nasdaq: RVSN, FSE: C80) (“Rail Vision” or the “Company”), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing ...

Global supply chains are shifting. Energy and manufacturing companies across the Gulf Coast are investing billions into ...

Researchers at Ouachita Baptist University are creating stitches loaded with anti-inflammatory drugs to deliver the ...

G.Network has been through an administrative reorganisation and has a new CEO at the helm to guide it through its next ...

The commentary titled 'Establishing a Commercial Solution for Extremely Rare Genetic Diseases' was published in Nature Biotechnology Commentary coincides with draft guidance from the FDA outlining a ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

The government has launched a 7,500 billion Korean won support project over two years to accelerate the commercialization of products applying artificial intelligence (AI) technology. The goal is to ...

Deep cuts from accidents or surgeries require stitches, typically followed by oral anti-inflammatory medications like ...

"The window to shape the oral GLP-1 market is open now...."Early-stage discussions with several multinational pharmaceutical ...

A new Tucson startup is developing technology that could store solar power during the day and release it to the electric grid ...

A proposed 50% tax on OnlyFans creators raises new questions about sin taxes, income targeting, and the role of policy in ...